Specialty pharmaceutical company Intelliject has received the US Food and Drug Administration(FDA)approval for its Auvi-Q(epinephrine injection,USP)used in the emergency treatment of life-threatening allergic reactions in people who are at ...
Tags: Specialty pharmaceutical company, Auvi-Q, Spencer Williamson, FDA
Specialty pharmaceutical company, BioSyent Inc., said its subsidiary BioSyent Pharma has launched a sterile topical anesthetic called Cathejell Jelly 2% for the Canadian healthcare market. Cathejell Jelly 2% combines a sterile gel and ...
Tags: Sterile Anesthetic, Cathejell Jelly 2%, Canadian healthcare
Specialty pharmaceutical company TherapeuticsMD has selected StayinFront's mobile customer relationship management (CRM) and EdgeRx solution. TherapeuticsMD will deploy mobile CRM solution, TouchRx, on iPads, which will enable its field ...
Tags: customer relationship management, pharmaceutical company
Jazz Pharmaceuticals, a specialty pharmaceutical company, has announced the issuance of new formulation patent for Xyrem (sodium oxybate) oral solution. Xyrem (sodium oxybate) oral solution is the FDA approved product for the ...
Tags: xyrem, cataplexy, patent, pharmaceutical product
Cytochroma, a clinical stage specialty pharmaceutical company, has selected OmniComm Systems' eClinical Suite of applications for its two Phase III studies. OmniComm's eClinical Suite, including the EDC, CTMS, Safety, and Coding ...
Tags: Cytochroma, clinical stage, eClinical Suite, patient data, adverse events
Sagent Pharmaceuticals, a specialty pharmaceutical company, has introduced Oxacillin for injection, USP, in three latex-free, preservative-free vial presentations. Oxacillin for Injection, USP, is a semisynthetic penicillin indicated in ...
Cornerstone Therapeutics has acquired a privately-held specialty pharmaceutical company focused on the acute-care hospital setting, EKR Therapeutics. As part of the merger, Cornerstone will assume the responsibility to market and promote ...
Tags: Cornerstone Therapeutics
Cornerstone Therapeutics, a specialty pharmaceutical company, has received FDA approval for its abbreviated new drug application (ANDA) for a generic Hydrocodone Polistirex and Chlorpheniramine Polistirex extended-release suspension ...
Tags: FDA approval, pharmaceutical product, generic antitussive product
Cipher Pharmaceuticals, a specialty pharmaceutical company, has received FDA approval for Absorica for the treatment of severe recalcitrant nodular acne. The company expects to launch its patented brand formulation of the acne ...
BioDelivery Sciences International (BDSI) announced that the USPTO has granted BDSI's patent which extends the patent protection for BioErodible MucoAdhesive (BEMA) products, BEMA Buprenorphine and BEMA Buprenorphine/Naloxone, by seven ...
Valeant Pharmaceuticals has purchased Pedinol Pharmacal and the transaction is expected to be immediately accretive. Pedinol Pharmacal is a podiatry-focused, privately-owned specialty pharmaceutical company based in the US. Valeant ...